The Mechanical Properties of Dry, Electrospun Fibrinogen Fibers.

Materials Science & Engineering. C, Materials for Biological Applications
Stephen BakerMartin Guthold

Abstract

Due to their low immunogenicity, biodegradability and native cell-binding domains, fibrinogen fibers may be good candidates for tissue engineering scaffolds, drug delivery vehicles and other medical devices. We used a combined atomic force microscope (AFM)/optical microscope technique to study the mechanical properties of individual, electrospun fibrinogen fibers in dry, ambient conditions. The AFM was used to stretch individual fibers suspended over 13.5 µm wide grooves in a transparent substrate. The optical microscope, located below the sample, was used to monitor the stretching process. Electrospun fibrinogen fibers (diameter, 30-200 nm) can stretch to 74 % beyond their original length before rupturing at a stress of 2.1 GPa. They can stretch elastically up to 15 % beyond their original length. Using incremental stress-strain curves the viscoelastic behavior of these fibers was determined. The total stretch modulus was 4.2 GPa while the relaxed elastic modulus was 3.7 GPa. When held at constant strain, fibrinogen fibers display stress relaxation with a fast and slow relaxation time of 1.2 s and 11 s.In comparison to native and electrospun collagen fibers, dry electrospun fibrinogen fibers are significantly more extensible a...Continue Reading

References

Sep 1, 1993·The American Review of Respiratory Disease·S Q Liu, Y C Fung
Nov 17, 2001·Biomacromolecules·F H SilverW J Landis
Oct 15, 2005·Circulation Research·Ivan Vesely
Aug 23, 2006·Cell·Adam J EnglerDennis E Discher
Dec 18, 2007·Biomaterials·Lanti YangJan Feijen
Jul 22, 2008·Biomaterials·Sangamesh G KumbarCato T Laurencin
Dec 9, 2008·Biomaterials·Christine R CarlisleMartin Guthold

❮ Previous
Next ❯

Citations

Oct 23, 2012·Journal of Biomechanical Engineering·Timothy J FeeJoel L Berry
Dec 1, 2015·Expert Review of Medical Devices·Vincenzo GuarinoLuigi Ambrosio
Dec 15, 2015·Materials Science & Engineering. C, Materials for Biological Applications·Stephen R BakerMartin Guthold
Aug 8, 2015·Materials Science & Engineering. C, Materials for Biological Applications·Soghra Ramazani, Mohammad Karimi
Mar 31, 2015·Clinical Hemorheology and Microcirculation·A AqilC Jérôme
Apr 29, 2016·Journal of the Mechanical Behavior of Biomedical Materials·Soghra Ramazani, Mohammad Karimi
Feb 25, 2015·Micron : the International Research and Review Journal for Microscopy·Adrian ChlandaKrzysztof J Kurzydlowski
Nov 6, 2014·Regenerative Medicine·Esen SayinVasif Hasirci
May 31, 2016·Journal of Tissue Engineering and Regenerative Medicine·D GugutkovG Altankov
Mar 5, 2019·Biofabrication·Karsten StapelfeldtDorothea Brüggemann
Nov 30, 2013·Biomedical Materials·Raul MachadoMargarida Casal
Nov 28, 2019·Journal of Biomaterials Science. Polymer Edition·Fangwen ZhaDemei Yu
Nov 9, 2019·Nano Convergence·Sorour NematiHeungsoo Shin
Jul 28, 2016·Journal of Materials Chemistry. B, Materials for Biology and Medicine·E Mele
Jun 27, 2020·Biomedical Materials·Juliana Girón BastidasPatricia Pranke
Mar 27, 2018·Bio-medical Materials and Engineering·Mohamad Javad Mirzaei-ParsaReza Faridi-Majidi
Oct 28, 2013·Biomaterials Science·Dencho GugutkovGeorge Altankov
Aug 21, 2017·Polymers·Jagoba Iturri, José L Toca-Herrera
Sep 19, 2020·Nanomaterials·Jacquelyn M SharpeMartin Guthold
Oct 23, 2020·Journal of the Mechanical Behavior of Biomedical Materials·Hugues MondésertDenis Favier
May 14, 2021·Informatics in Medicine Unlocked·Sumith Yesudasan, Rodney D Averett
Jun 5, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Naiana SuterDorothea Brüggemann
Jun 30, 2021·Proceedings of the National Academy of Sciences of the United States of America·Cédric DuvalRobert A S Ariëns
Jul 20, 2018·ACS Omega·Lijuan HouRobert J Linhardt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.